Dopamine D2 densities and the schizophrenic brain

Meta-analytic methods were used to test the D2 dopamine density hypothesis in schizophrenia. Post-mortem as well as in-vivo (i.e., PET and SPECT) neuroimaging studies that met criteria for inclusion into the meta-analysis were gathered from 1980 to 1996. The mean effect size across studies corresponds to an effect size of 1.47 (d). Although large, the effect size obtained does not meet heuristic benchmark criteria that would suggest D2 density increases to be a marker for schizophrenia. That is, roughly 30% of patients with schizophrenia could not be discriminated from normal healthy controls. Based on the findings, it is argued that D2 density receptor increases in patients with schizophrenia, although a reliable finding in many patients (i.e., approximately 70%), is not a specific or consistent marker for schizophrenia.

[1]  G. Pearlson,et al.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.

[2]  S. Stone-Elander,et al.  No D2 receptor increase in PET study of schizophrenia. , 1987, Archives of general psychiatry.

[3]  R. Heinrichs,et al.  Neurocognitive subtypes of chronic schizophrenia , 1993, Schizophrenia Research.

[4]  J. Kleinman,et al.  Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients , 1994, Biological Psychiatry.

[5]  P. Seeman,et al.  Elevation of brain neuroleptic/dopamine receptors in schizophrenia. , 1980, The American journal of psychiatry.

[6]  T. Kuno,et al.  Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics , 1986, Biological Psychiatry.

[7]  S. Taylor,et al.  Cerebral blood flow activation and functional lesions in schizophrenia , 1996, Schizophrenia Research.

[8]  P Riederer,et al.  Bimodal distribution of dopamine receptor densities in brains of schizophrenics. , 1984, Science.

[9]  G. Reynolds,et al.  Are Striatal Dopamine D4 Receptors Increased in Schizophrenia? , 1994, Journal of neurochemistry.

[10]  S. Levin.  Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions. , 1984, Journal of psychiatric research.

[11]  K. Zakzanis.  Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type. , 1998, Journal of clinical and experimental neuropsychology.

[12]  Alan A. Wilson,et al.  Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone , 1993, Psychiatry Research.

[13]  Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. , 1990 .

[14]  D. Ingvar,et al.  Absence of activation in frontal structures during psychological testing of chronic schizophrenics. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[15]  P. McKenna,et al.  Schizophrenia – a Brain Disease? a Critical Review of Structural and Functional Cerebral Abnormality in the Disorder , 1995, British Journal of Psychiatry.

[16]  B. Mazoyer,et al.  Central D2 Receptors and Negative Symptoms of Schizophrenia , 1994, British Journal of Psychiatry.

[17]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[18]  G. Sedvall,et al.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.

[19]  R. Murray,et al.  D2 Dopamine Receptor Binding in the Basal Ganglia of Antipsychotic-Free Schizophrenic Patients , 1994, British Journal of Psychiatry.

[20]  R. Heinrichs.  Schizophrenia and the brain. Conditions for a neuropsychology of madness. , 1993, The American psychologist.

[21]  N. Andreasen.  The Broken Brain: The Biological Revolution in Psychiatry , 1984 .

[22]  Konstantine K. Zakzanis,et al.  Neurocognitive Deficit in Schizophrenia: A Quantitative Review of the Evidence , 1998 .

[23]  M M Mesulam,et al.  Schizophrenia and the brain. , 1990, The New England journal of medicine.

[24]  J. Rawlins,et al.  The neuropsychology of schizophrenia , 1991, Behavioral and Brain Sciences.

[25]  J. Kleinman,et al.  Dopamine receptor subtype imbalance in schizophrenia. , 1987, Life sciences.

[26]  R. Kerwin,et al.  Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia , 1994, Psychological Medicine.

[27]  L. Seidman.  Schizophrenia and brain dysfunction: an integration of recent neurodiagnostic findings , 1983 .

[28]  S. Stone-Elander,et al.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.

[29]  R. Heinrichs,et al.  Parsing Schizophrenia with Neurocognitive Tests: Evidence of Stability and Validity , 1997, Brain and Cognition.

[30]  V. Lehtinen,et al.  Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. , 1994, Archives of general psychiatry.